COLL vs CRON
Collegium Pharmaceutical Inc · Cronos Group Inc
Relative return (rebased to 100)
Key stats
| Metric | COLL | CRON |
|---|---|---|
| Price | $23.73 | $3.38 |
| Market Cap | $772.54M | $1.25B |
| P/E | 12.29 | — |
| P/B | 2.48 | 1.17 |
| P/S | 0.99 | 8.49 |
| ROE | 20.2% | -0.9% |
| Net Margin | 8.1% | -6.4% |
| Gross Margin | 59.3% | 42.8% |
| Revenue Growth | 23.6% | 24.6% |
| Dividend Yield | — | — |
| EPS | $1.93 | -$0.03 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.